AstraZeneca

In News

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says - Reuters

Reuters - Aug 05, 2026

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBC

CNBC - Aug 06, 2026

AstraZeneca, CSPC to form joint venture for biologics manufacturing - Fierce Pharma

Fierce Pharma - Aug 05, 2026

No $400B Mega Merger? AstraZeneca Rises, Bristol Myers Falls as Report Denies Deal - TipRanks

TipRanks - Aug 05, 2026

AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up - Financial Times

Financial Times - Aug 03, 2026

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’ - MarketWatch

MarketWatch - Aug 03, 2026

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’ - The Guardian

The Guardian - Jul 27, 2026

AstraZeneca profit beat, bullish tone ease worries over drug pipeline - Reuters

Reuters - Jul 27, 2026

Merger talks between AstraZeneca, Bristol Myers are off — report - Endpoints News

Endpoints News - Aug 05, 2026

What the AstraZeneca-BMS rumors reveal about pharma megamergers - Pharma Voice

Pharma Voice - Aug 06, 2026

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled. - BioPharma Dive

BioPharma Dive - Aug 03, 2026

Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition - Pharmaceutical Executive

Pharmaceutical Executive - Aug 05, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment